Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
About this item
Full title
Author / Creator
Publisher
Boston: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
Boston: Springer US
Subjects
More information
Scope and Contents
Contents
This study was designed to evaluate the efficacy and safety of irinotecan in combination with carboplatin in previously untreated, extensive-disease small-cell lung cancer (ED-SCLC). Patients with histologically or cytologically confirmed ED-SCLC received irinotecan (60 mg/m
2
on days 1, 8, and 15) plus carboplatin (AUC 5 on day 1) every 4 we...
Alternative Titles
Full title
Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_853996800
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_853996800
Other Identifiers
ISSN
1357-0560
E-ISSN
1559-131X
DOI
10.1007/s12032-010-9453-z
